ORIC vs VSTM
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
ORIC · Oric Pharmaceuticals$7.36 ▼ 4.42%
VSTM · Verastem$6.33 ▼ 7.73%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- ORIC -37.6%
- VSTM -35.7%
Head to head
| Metric | ORIC | VSTM |
|---|---|---|
| Price | $7.36 | $6.33 |
| Change today | ▼ 4.42% | ▼ 7.73% |
| Market cap | $764.94M | $797.67M |
| Return, 3 months | -45.3% | -7.7% |
| Return, year to date | -10.0% | -18.0% |
| Return, 1 year | -36.7% | -36.7% |
| P/E (TTM) | – | – |
| P/B | 2.3 | 79.1 |
| P/E percentile vs own 5y | 26th | 1st |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | +113.6% |
| Net profit growth (YoY) | -14.1% | +24.2% |
| Gross margin | – | 86.1% |
| Operating margin | – | -193.7% |
| Net margin | – | -178.4% |
| Return on equity | -39.8% | – |
| Analyst target vs. price | +220.2% | +192.3% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 32 | 28 |
| 30-day volatility | 132.9% | 94.6% |
| Max drawdown, 1 year | -49.8% | -67.6% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- VSTM is the largest of the group by market value.
- ORIC has returned the most over the past year.
- VSTM has been the calmest stock over the last 30 days.